198 related articles for article (PubMed ID: 37612044)
21. FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.
Ding Y; Wilkinson A; Idris A; Fancke B; O'Keeffe M; Khalil D; Ju X; Lahoud MH; Caminschi I; Shortman K; Rodwell R; Vuckovic S; Radford KJ
J Immunol; 2014 Feb; 192(4):1982-9. PubMed ID: 24453245
[TBL] [Abstract][Full Text] [Related]
22. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.
Schnurr M; Chen Q; Shin A; Chen W; Toy T; Jenderek C; Green S; Miloradovic L; Drane D; Davis ID; Villadangos J; Shortman K; Maraskovsky E; Cebon J
Blood; 2005 Mar; 105(6):2465-72. PubMed ID: 15546948
[TBL] [Abstract][Full Text] [Related]
23. Differential uptake and cross-presentation of soluble and necrotic cell antigen by human DC subsets.
Chiang MC; Tullett KM; Lee YS; Idris A; Ding Y; McDonald KJ; Kassianos A; Leal Rojas IM; Jeet V; Lahoud MH; Radford KJ
Eur J Immunol; 2016 Feb; 46(2):329-39. PubMed ID: 26542182
[TBL] [Abstract][Full Text] [Related]
24. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
25. Human CD141
Minoda Y; Virshup I; Leal Rojas I; Haigh O; Wong Y; Miles JJ; Wells CA; Radford KJ
Front Immunol; 2017; 8():1419. PubMed ID: 29163495
[TBL] [Abstract][Full Text] [Related]
26. Precise Delineation and Transcriptional Characterization of Bovine Blood Dendritic-Cell and Monocyte Subsets.
Talker SC; Baumann A; Barut GT; Keller I; Bruggmann R; Summerfield A
Front Immunol; 2018; 9():2505. PubMed ID: 30425716
[TBL] [Abstract][Full Text] [Related]
27. Targeting dendritic cells to advance cross-presentation and vaccination outcomes.
Macri C; Jenika D; Ouslinis C; Mintern JD
Semin Immunol; 2023 Jul; 68():101762. PubMed ID: 37167898
[TBL] [Abstract][Full Text] [Related]
28. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
[TBL] [Abstract][Full Text] [Related]
29. Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.
Noubade R; Majri-Morrison S; Tarbell KV
Front Immunol; 2019; 10():1014. PubMed ID: 31143179
[TBL] [Abstract][Full Text] [Related]
30. Migratory CD11b
Krishnaswamy JK; Gowthaman U; Zhang B; Mattsson J; Szeponik L; Liu D; Wu R; White T; Calabro S; Xu L; Collet MA; Yurieva M; Alsén S; Fogelstrand P; Walter A; Heath WR; Mueller SN; Yrlid U; Williams A; Eisenbarth SC
Sci Immunol; 2017 Dec; 2(18):. PubMed ID: 29196450
[TBL] [Abstract][Full Text] [Related]
31. Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.
Wang H; Yu X; Guo C; Zuo D; Fisher PB; Subjeck JR; Wang XY
J Immunol; 2013 Dec; 191(12):6010-21. PubMed ID: 24218449
[TBL] [Abstract][Full Text] [Related]
32. Subsets of CD1c
Heger L; Hofer TP; Bigley V; de Vries IJM; Dalod M; Dudziak D; Ziegler-Heitbrock L
Front Immunol; 2020; 11():559166. PubMed ID: 33101275
[TBL] [Abstract][Full Text] [Related]
33. Bioinspired vaccines to enhance MHC class-I antigen cross-presentation.
Baljon JJ; Wilson JT
Curr Opin Immunol; 2022 Aug; 77():102215. PubMed ID: 35667222
[TBL] [Abstract][Full Text] [Related]
34. PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8
Chaib M; Sipe LM; Yarbro JR; Bohm MS; Counts BR; Tanveer U; Pingili AK; Daria D; Marion TN; Carson JA; Thomas PG; Makowski L
Cancer Lett; 2022 Apr; 531():98-108. PubMed ID: 35074498
[TBL] [Abstract][Full Text] [Related]
35. Targeting interferon-alpha to dendritic cells enhances a CD8
Graham JP; Authie P; Karolina Palucka A; Zurawski G
Vaccine; 2017 Aug; 35(35 Pt B):4532-4539. PubMed ID: 28743486
[TBL] [Abstract][Full Text] [Related]
36. CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease.
De Luca A; Iannitti RG; Bozza S; Beau R; Casagrande A; D'Angelo C; Moretti S; Cunha C; Giovannini G; Massi-Benedetti C; Carvalho A; Boon L; Latgé JP; Romani L
J Clin Invest; 2012 May; 122(5):1816-31. PubMed ID: 22523066
[TBL] [Abstract][Full Text] [Related]
37. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
[TBL] [Abstract][Full Text] [Related]
38. Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis.
Sasaki I; Kato T; Hemmi H; Fukuda-Ohta Y; Wakaki-Nishiyama N; Yamamoto A; Kaisho T
Front Immunol; 2022; 13():857954. PubMed ID: 35693801
[TBL] [Abstract][Full Text] [Related]
39. Effective Priming of Herpes Simplex Virus-Specific CD8
Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130
[TBL] [Abstract][Full Text] [Related]
40. A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.
Santone M; Aprea S; Wu TY; Cooke MP; Mbow ML; Valiante NM; Rush JS; Dougan S; Avalos A; Ploegh H; De Gregorio E; Buonsanti C; D'Oro U
Hum Vaccin Immunother; 2015; 11(8):2038-50. PubMed ID: 26024409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
